CD8A and neoplasm: To test this hypothesis, WT mice were given TBL-OVA tumor cells and treated with 1 μg alpha-GalCer 1,5, and 9 days after tumor transplant, and CD8+ T cell responses were analyzed on day 11, (Figure 7A).